SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Jan-24 7:06 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 19-Jan-24 | Sale (Planned) | 8,933 | $3.48 | $31,048.40 | (8%) 117.8K to 108.87K | |
04-Jan-24 4:22 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 91,000 | -- | -- | 340% 26.8K to 117.8K | |
18-Jan-23 4:21 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 26,800 | -- | -- | 100% 0 to 26.8K | |
19-Aug-22 1:08 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-22 | Sale (Planned) | 8,334 | -- | -- | (5%) 153.49K to 145.16K | |
27-Jun-22 4:08 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Jun-22 | Sale | 4,166 | -- | -- | (3%) 157.66K to 153.49K | |
17-Jun-22 4:21 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 16-Jun-22 | Sale (Planned) | 4,166 | -- | -- | (3%) 161.82K to 157.66K | |
01-Mar-22 10:00 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Mar-22 | Grant | 105,000 | -- | -- | 185% 56.82K to 161.82K | |
14-Feb-22 10:00 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Feb-22 | Sale (Planned) | 15,909 | -- | -- | (22%) 72.73K to 56.82K | |
19-Aug-21 4:26 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-21 | Market Sale (Planned) | 8,332 | $5.10 | $42,493.20 | (10%) 81.06K to 72.73K | 4% |
25-Jun-21 4:03 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Jun-21 | Market Sale (Planned) | 4,166 | $7.00 | $29,162.00 | (5%) 85.23K to 81.06K | |
25-Jun-21 4:03 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-21 | Grant | 12,500 | -- | -- | 17% 72.73K to 85.23K | |
17-Jun-21 5:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-21 | Grant | 12,500 | -- | -- | 19% 64.39K to 76.89K | |
17-Jun-21 5:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-21 | Market Sale (Planned) | 4,166 | $7.84 | $32,661.40 | (5%) 76.89K to 72.73K | |
25-Mar-21 4:54 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Mar-21 | Grant | 47,728 | -- | -- | 286% 16.67K to 64.39K | |
10-Sep-20 8:31 AM View: | X4 Pharmaceuticals, Inc (XFOR) | 09-Sep-20 | Market Sale (Planned) | 8,334 | $8.05 | $67,088.70 | (33%) 25.0K to 16.67K | 20% |
18-Aug-20 8:11 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-20 | Grant | 12,500 | -- | -- | 100% 12.5K to 25.0K | |
18-Aug-20 8:11 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 14-Aug-20 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K |